4.3 Article

Specificity profiling of human trypsin-isoenzymes

期刊

BIOLOGICAL CHEMISTRY
卷 399, 期 9, 页码 997-1007

出版社

WALTER DE GRUYTER GMBH
DOI: 10.1515/hsz-2018-0107

关键词

profiling; protease; specificity; substrate-assisted catalysis; trypsin

资金

  1. Finnish Cancer Foundation
  2. Sigrid Juselius Foundation
  3. Finnish Society of Clinical Chemistry
  4. Deutsche Forschungsgemeinschaft [SCHI 871/5, SCHI 871/8, SCHI 871/9, SCHI 871/11, INST 39/900-1, SFB850]
  5. Excellence Initiative of the German Federal and State Governments (BIOSS) [EXC 294]
  6. European Research Council [PoC 780730]
  7. German-Israeli Foundation for Scientific Research and Development [1444]

向作者/读者索取更多资源

In humans, three different trypsin-isoenzymes have been described. Of these, trypsin-3 appears to be functionally different from the others. In order to systematically study the specificity of the trypsin-isoenzymes, we utilized proteome-derived peptide libraries and quantitative proteomics. We found similar specificity profiles dominated by the well-characterized preference for cleavage after lysine and arginine. Especially, trypsin-1 slightly favored lysine over arginine in this position, while trypsin-3 did not discriminate between them. In the P1' position, which is the residue C-terminal to the cleavage site, we noticed a subtle enrichment of alanine and glycine for all three trypsins and for trypsin-3 there were additional minor P1' and P2' preferences for threonine and aspartic acid, respectively. These findings were confirmed by FRET peptide substrates showing different susceptibility to cleavage by different trypsins. The preference of trypsin-3 for aspartic acid in P2' is explained by salt bridge formation with the unique Arg193. This salt bridge enables and stabilizes a canonical oxyanion conformation by the amides of Ser195 and Arg193, thus manifesting a selective substrate-assisted catalysis. As trypsin-3 has been proposed to be a therapeutic target and marker for cancers, our results may aid the development of specific inhibitors for cancer therapy and diagnostic probes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据